+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Effect of molecular structure on the performance of triarylmethane dyes as therapeutic agents for photochemical purging of autologous bone marrow grafts from residual tumor cells



Effect of molecular structure on the performance of triarylmethane dyes as therapeutic agents for photochemical purging of autologous bone marrow grafts from residual tumor cells



Journal of Pharmaceutical Sciences 89(1): 88-99



Extensively conjugated cationic molecules with appropriate structural features naturally accumulate into the mitochondria of living cells, a phenomenon typically more prominent in tumor than in normal cells. Because a variety of tumor cells also retain pertinent cationic structures for longer periods of time compared with normal cells, mitochondrial targeting has been proposed as a selective therapeutic strategy of relevance for both chemotherapy and photochemotherapy of neoplastic diseases. Here we report that the triarylmethane dye crystal violet stains cell mitochondria with efficiency and selectivity, and is a promising candidate for photochemotherapy applications. Crystal violet exhibits pronounced phototoxicity toward L1210 leukemia cells but comparatively small toxic effects toward normal hematopoietic cells (murine granulocyte-macrophage progenitors, CFU-GM). On the basis of a comparative examination of chemical, photochemical, and phototoxic properties of crystal violet and other triarylmethane dyes, we have identified interdependencies between molecular structure, and selective phototoxicity toward tumor cells. These structure-activity relationships represent useful guidelines for the development of novel purging protocols to promote selective elimination of residual tumor cells from autologous bone marrow grafts with minimum toxicity to normal hematopoietic stem cells.

(PDF emailed within 0-6 h: $19.90)

Accession: 010529436

Download citation: RISBibTeXText

PMID: 10664541

DOI: 10.1002/(sici)1520-6017(200001)89:1<88::aid-jps9>3.0.co;2-k


Related references

Triarylmethane dyes as therapeutic agents for the photochemical purging of autologous bone marrow grafts from residual tumor cells. Biophysical Journal 78(1 Part 2): 256A, 2000

Photochemical purging of autologous bone marrow grafts: Assessment of damage to stem cells and the microenvironment in long-term marrow cultures. Bone Marrow Transplantation 20(1): 27-31, 1997

The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts. Progress in Clinical and Biological Research 389: 601-609, 1994

Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. Experimental Hematology 25(7): 629-637, 1997

Effect of molecular structure on the selective phototoxicity of triarylmethane dyes towards tumor cells. Photochemical & Photobiological Sciences 1(5): 309-314, 2002

Effect of molecular structure on the selective phototoxicity of triarylmethane dyes towards tumor cells. Photochemical and Photobiological Sciences 1(5): 309-314, 2003

Elimination of residual tumor cells from autologous bone marrow grafts using monoclonal antibodies. Oldham, R K (Ed ) Principles Of Cancer Biotherapy X+502p Raven Press: New York, New York, Usa Illus 355-384, 1987

Elimination of residual tumor cells from autologous bone marrow grafts by dye-mediated photolysis: preclinical data. Photochemistry and Photobiology 46(1): 71-76, 1987

Ethacrynic acid enhances the merocyanine 540-mediated purging of leukemia cells from autologous bone marrow grafts. Blood 86(10 SUPPL 1): 235A, 1995

Autologous bone marrow transplantation after purging by low molecular weight natural tumor suppressor in long-term marrow culture in vitro: report on 2 cases. Zhonghua Nei Ke Za Zhi 30(8): 495-7, 522, 1991

Transferrin ricin a chain for ex vivo purging of small cell carcinoma cells from autologous bone marrow grafts. Clinical Research 38(1): 17A, 1990

A two-phase approach to B lymphocyte purging of autologous bone marrow grafts for patients with malignant lymphoma contaminated bone marrow. Progress in Clinical and Biological Research 389: 105-109, 1994

Residual leukemic cells in autologous marrow grafts do not significantly contribute to leukemia relapse after bone marrow transplantation. Experimental Hematology 16(6): 492, 1988

Low antigen density tumor cells: an obstacle to effective autologous bone marrow purging?. Cancer Investigation 5(2): 113-118, 1987

Photoradiation methods for purging autologous bone marrow grafts. Progress in Clinical and Biological Research 333: 87-102, 1990